BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27598809)

  • 1. Direction Modulated Brachytherapy for Treatment of Cervical Cancer. II: Comparative Planning Study With Intracavitary and Intracavitary-Interstitial Techniques.
    Han DY; Safigholi H; Soliman A; Ravi A; Leung E; Scanderbeg DJ; Liu Z; Owrangi A; Song WY
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):440-448. PubMed ID: 27598809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
    Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
    Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical design.
    Han DY; Webster MJ; Scanderbeg DJ; Yashar C; Choi D; Song B; Devic S; Ravi A; Song WY
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):666-73. PubMed ID: 24751413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direction modulated brachytherapy (DMBT) tandem applicator for cervical cancer treatment: Choosing the optimal shielding material.
    Safigholi H; Han DY; Soliman A; Song WY
    Med Phys; 2018 Jun; ():. PubMed ID: 29858499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
    Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
    Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.
    Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA
    Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.
    Nomden CN; de Leeuw AA; Van Limbergen E; de Brabandere M; Nulens A; Nout RA; Laman M; Ketelaars M; Lutgens L; Reniers B; Jürgenliemk-Schulz IM
    Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
    Kirisits C; Lang S; Dimopoulos J; Berger D; Georg D; Pötter R
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):624-30. PubMed ID: 16690444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The addition of interstitial needles to intracavitary applicators in the treatment of locally advanced cervical cancer: Why is this important and how to implement in low- and middle-income countries?
    Lombe D; Crook J; Bachand F; Moore J; Hamm J; Rose T; Anderson D; Batchelar D
    Brachytherapy; 2020; 19(3):316-322. PubMed ID: 32229073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of the direction modulated brachytherapy tandem applicator using the Oncentra Brachy advanced collapsed cone engine.
    Safigholi H; van Veelen B; Niatsetski Y; Song WY
    Brachytherapy; 2018; 17(6):1030-1036. PubMed ID: 30181054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy.
    Schnell E; Thompson S; Ahmad S; Herman TS; De La Fuente Herman T
    Med Dosim; 2020 Spring; 45(1):21-27. PubMed ID: 31101569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
    Fredman E; Traughber B; Podder T; Colussi V; Zheng Y; Russo S; Herrmann K; Paspulati R; Waggoner S; Zanotti K; Nagel C; Nakayama J; Machtay M; Ellis R
    Brachytherapy; 2018; 17(2):334-344. PubMed ID: 29097137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic modulated brachytherapy (DMBT) for rectal cancer.
    Webster MJ; Devic S; Vuong T; Yup Han D; Park JC; Scanderbeg D; Lawson J; Song B; Tyler Watkins W; Pawlicki T; Song WY
    Med Phys; 2013 Jan; 40(1):011718. PubMed ID: 23298088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
    Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
    Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component.
    Fokdal L; Tanderup K; Hokland SB; Røhl L; Pedersen EM; Nielsen SK; Paludan M; Lindegaard JC
    Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame.
    Trnková P; Pötter R; Baltas D; Karabis A; Fidarova E; Dimopoulos J; Georg D; Kirisits C
    Radiother Oncol; 2009 Nov; 93(2):331-40. PubMed ID: 19846230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose Distribution Optimization in Combined Intracavitary and Interstitial Brachytherapy for Cervical Cancer].
    Ozaki D; Miyazawa M; Habano Y; Kawashima M; Hoshino Y; Sutou T
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2018; 74(4):354-361. PubMed ID: 29681602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting which patients may benefit from the hybrid intracavitary+interstitial needle (IC/IS) applicator for advanced cervical cancer: A dosimetric comparison and toxicity benefit analysis.
    Gonzalez Y; Giap F; Klages P; Owrangi A; Jia X; Albuquerque K
    Brachytherapy; 2021; 20(1):136-145. PubMed ID: 33132073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric evaluation of the feasibility of utilizing a reduced number of interstitial needles in combined intracavitary and interstitial brachytherapy for cervical cancer.
    Jahan D; Ahmad S; Thompson S; Schnell E
    J Appl Clin Med Phys; 2023 Feb; 24(2):e13833. PubMed ID: 36355039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.